We also found that the total cholesterol, triglyceride, HDL-C, LDL-C, lipoprotein (a), APOA1, and APOB levels were significantly altered in TB patients (Table 4), indicating that lipid metabolism biomarkers might be used as indicators for anti-TB treatment. The gene discussed is APOB; the disease is tuberculosis.